These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37167276)

  • 21. Current and emerging medications for the treatment of leishmaniasis.
    Chakravarty J; Sundar S
    Expert Opin Pharmacother; 2019 Jul; 20(10):1251-1265. PubMed ID: 31063412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leishmaniasis and Trace Element Alterations: a Systematic Review.
    Taghipour A; Abdoli A; Ramezani A; Abolghazi A; Mofazzal Jahromi MA; Maani S; Heidar Nejadi SM; Rasti S; Shams M; Ghasemi E
    Biol Trace Elem Res; 2021 Oct; 199(10):3918-3938. PubMed ID: 33405078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.
    Garrido-Jareño M; Sahuquillo-Torralba A; Chouman-Arcas R; Castro-Hernández I; Molina-Moreno JM; Llavador-Ros M; Gómez-Ruiz MD; López-Hontangas JL; Botella-Estrada R; Salavert-Lleti M; Pemán-García J
    Parasit Vectors; 2020 Jan; 13(1):24. PubMed ID: 31931865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial burden of localised cutaneous Leishmaniasis: a scoping review.
    Bennis I; De Brouwere V; Belrhiti Z; Sahibi H; Boelaert M
    BMC Public Health; 2018 Mar; 18(1):358. PubMed ID: 29544463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of the effects of environmental and ecologic factors on cutaneous leishmaniasis in the old world: a systematic review study.
    Mohammadbeigi A; Khazaei S; Heidari H; Asgarian A; Arsangjang S; Saghafipour A; Mohammadsalehi N; Ansari H
    Rev Environ Health; 2021 Mar; 36(1):117-128. PubMed ID: 32892182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
    Zijlstra EE
    PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of vector control methods for the control of cutaneous and visceral leishmaniasis: A meta-review.
    Montenegro Quiñonez CA; Runge-Ranzinger S; Rahman KM; Horstick O
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009309. PubMed ID: 33983930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for a systematic review and meta-analysis of studies on the use of brain natriuretic peptide and N-terminal brain natriuretic peptide levels in the diagnosis of cardiopulmonary edema in acute respiratory failure.
    Terayama T; Taniguchi T; Imai R; Anan K; Yoshida T; Ando K; Okamori S; Okada Y
    Syst Rev; 2021 Dec; 10(1):314. PubMed ID: 34911558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stigma associated with cutaneous leishmaniasis in rural Sri Lanka: development of a conceptual framework.
    Nuwangi H; Dikomitis L; Weerakoon KG; Liyanage C; Agampodi TC; Agampodi SB
    Int Health; 2024 Mar; ():. PubMed ID: 38487983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany].
    Boecken G; Sunderkötter C; Bogdan C; Weitzel T; Fischer M; Müller A; Löbermann M; Anders G; von Stebut E; Schunk M; Burchard G; Grobusch M; Bialek R; Harms-Zwingenberger G; Fleischer B; Pietras M; Faulde M; Erkens K; ; ;
    J Dtsch Dermatol Ges; 2011 Nov; 9 Suppl 8():1-51. PubMed ID: 22050890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring Innovative Leishmaniasis Treatment: Drug Targets from Pre-Clinical to Clinical Findings.
    Santana W; de Oliveira SSC; Ramos MH; Santos ALS; Dolabella SS; Souto EB; Severino P; Jain S
    Chem Biodivers; 2021 Sep; 18(9):e2100336. PubMed ID: 34369662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
    Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Environmental and socioeconomic risk factors associated with visceral and cutaneous leishmaniasis: a systematic review.
    Valero NNH; Uriarte M
    Parasitol Res; 2020 Feb; 119(2):365-384. PubMed ID: 31897789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interruptions in contraception and unintended pregnancy during the COVID-19 pandemic: A protocol for systematic review and meta-analysis.
    Geleto A; Taylor J; Beyene T
    Womens Health (Lond); 2023; 19():17455057221147382. PubMed ID: 36633116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WHO/ILO work-related burden of disease and injury: Protocol for systematic reviews of occupational exposure to solar ultraviolet radiation and of the effect of occupational exposure to solar ultraviolet radiation on melanoma and non-melanoma skin cancer.
    Paulo MS; Adam B; Akagwu C; Akparibo I; Al-Rifai RH; Bazrafshan S; Gobba F; Green AC; Ivanov I; Kezic S; Leppink N; Loney T; Modenese A; Pega F; Peters CE; Prüss-Üstün AM; Tenkate T; Ujita Y; Wittlich M; John SM
    Environ Int; 2019 May; 126():804-815. PubMed ID: 30792021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis.
    Iranpour S; Hosseinzadeh A; Alipour A
    Epidemiol Health; 2019; 41():e2019011. PubMed ID: 30999735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular alterations in patients with cutaneous and mucocutaneous leishmaniasis.
    Wunderle II; de Kaspar HM; Cabrera E; de Arias AR; Froehlich SJ; de Bilbao NV; Insfran NS; Azorero RM; Klauss V
    Trop Doct; 2003 Apr; 33(2):112-5. PubMed ID: 12680552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measured and perceived impacts of evidence-based leadership in nursing: a mixed-methods systematic review protocol.
    Välimäki MA; Lantta T; Hipp K; Varpula J; Liu G; Tang Y; Chen W; Hu S; Li X
    BMJ Open; 2021 Oct; 11(10):e055356. PubMed ID: 34686559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal and mucocutaneous leishmaniasis in Iran from 1968 to 2018: a narrative review of clinical features, treatments, and outcomes.
    Sabzevari S; Mohebali M; Hashemi SA
    Int J Dermatol; 2020 May; 59(5):606-612. PubMed ID: 31943166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role and utility of COVID-19 laboratory testing in low-income and middle-income countries: protocol for rapid evidence synthesis.
    Ouma OK; Ephraim K; Loyce N; Namisango E; Nalugoda F; Ndagire R; Wangi RN; Kawala BA; Katairo T; Okullo AE; Apunyo R; Semakula D; Luwambo A; Kinengyere AA; Sewankambo N; Balinda SN; Ocan M; Obuku EA
    BMJ Open; 2021 Oct; 11(10):e050296. PubMed ID: 34663660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.